0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plaque Psoriasis Treatment Medications Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-25X17426
Home | Market Reports
Global Plaque Psoriasis Treatment Medications Market Research Report 2024
BUY CHAPTERS

Global Plaque Psoriasis Treatment Medications Market Research Report 2026

Code: QYRE-Auto-25X17426
Report
2026-03-20
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plaque Psoriasis Treatment Medications Market

The global Plaque Psoriasis Treatment Medications market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Plaque Psoriasis Treatment Medications competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Plaque psoriasis is the most common form of psoriasis, a chronic, relapsing autoimmune skin disease characterized by red, thick patches of skin with silvery white scales.
The North American market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Plaque Psoriasis Treatment Medications is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Plaque Psoriasis Treatment Medications include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Plaque Psoriasis Treatment Medications market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plaque Psoriasis Treatment Medications. The Plaque Psoriasis Treatment Medications market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Plaque Psoriasis Treatment Medications market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Plaque Psoriasis Treatment Medications manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Plaque Psoriasis Treatment Medications Market Report

Report Metric Details
Report Name Plaque Psoriasis Treatment Medications Market
Segment by Type
  • Biologics
  • Small Molecule Drugs
  • Non-biologic Drugs
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, LEO Pharma, Biogen, Galectin Therapeutics, Cellceutix, Bayer, Organon, UCB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Plaque Psoriasis Treatment Medications manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Plaque Psoriasis Treatment Medications sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Plaque Psoriasis Treatment Medications Market report?

Ans: The main players in the Plaque Psoriasis Treatment Medications Market are Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, LEO Pharma, Biogen, Galectin Therapeutics, Cellceutix, Bayer, Organon, UCB

What are the Application segmentation covered in the Plaque Psoriasis Treatment Medications Market report?

Ans: The Applications covered in the Plaque Psoriasis Treatment Medications Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Plaque Psoriasis Treatment Medications Market report?

Ans: The Types covered in the Plaque Psoriasis Treatment Medications Market report are Biologics, Small Molecule Drugs, Non-biologic Drugs

1 Plaque Psoriasis Treatment Medications Market Overview
1.1 Product Definition
1.2 Plaque Psoriasis Treatment Medications by Type
1.2.1 Global Plaque Psoriasis Treatment Medications Market Value by Type: 2025 vs 2032
1.2.2 Biologics
1.2.3 Small Molecule Drugs
1.2.4 Non-biologic Drugs
1.3 Plaque Psoriasis Treatment Medications by Application
1.3.1 Global Plaque Psoriasis Treatment Medications Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Plaque Psoriasis Treatment Medications Market Size Estimates and Forecasts
1.4.1 Global Plaque Psoriasis Treatment Medications Revenue 2021–2032
1.4.2 Global Plaque Psoriasis Treatment Medications Sales 2021–2032
1.4.3 Global Plaque Psoriasis Treatment Medications Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Plaque Psoriasis Treatment Medications Market Competition by Manufacturers
2.1 Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2021–2026)
2.2 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Plaque Psoriasis Treatment Medications Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Plaque Psoriasis Treatment Medications, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Product Types and Applications
2.7 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Date of Entry into the Industry
2.8 Global Plaque Psoriasis Treatment Medications Market Competitive Situation and Trends
2.8.1 Global Plaque Psoriasis Treatment Medications Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Plaque Psoriasis Treatment Medications Players Market Share by Revenue
2.8.3 Global Plaque Psoriasis Treatment Medications Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Plaque Psoriasis Treatment Medications Market Scenario by Region
3.1 Global Plaque Psoriasis Treatment Medications Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021–2032
3.2.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021–2026
3.2.2 Global Plaque Psoriasis Treatment Medications Sales by Region: 2027–2032
3.3 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2021–2032
3.3.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2021–2026
3.3.2 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2027–2032
3.4 North America Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
3.4.1 North America Plaque Psoriasis Treatment Medications Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Plaque Psoriasis Treatment Medications Sales by Country (2021–2032)
3.4.3 North America Plaque Psoriasis Treatment Medications Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
3.5.1 Europe Plaque Psoriasis Treatment Medications Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Plaque Psoriasis Treatment Medications Sales by Country (2021–2032)
3.5.3 Europe Plaque Psoriasis Treatment Medications Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plaque Psoriasis Treatment Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Plaque Psoriasis Treatment Medications Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Plaque Psoriasis Treatment Medications Sales by Region (2021–2032)
3.6.3 Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
3.7.1 Latin America Plaque Psoriasis Treatment Medications Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Plaque Psoriasis Treatment Medications Sales by Country (2021–2032)
3.7.3 Latin America Plaque Psoriasis Treatment Medications Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Plaque Psoriasis Treatment Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Plaque Psoriasis Treatment Medications Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2021–2032)
3.8.3 Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021–2032)
4.1.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021–2026)
4.1.2 Global Plaque Psoriasis Treatment Medications Sales by Type (2027–2032)
4.1.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021–2032)
4.2 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021–2032)
4.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021–2026)
4.2.2 Global Plaque Psoriasis Treatment Medications Revenue by Type (2027–2032)
4.2.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021–2032)
4.3 Global Plaque Psoriasis Treatment Medications Price by Type (2021–2032)
5 Segment by Application
5.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021–2032)
5.1.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021–2026)
5.1.2 Global Plaque Psoriasis Treatment Medications Sales by Application (2027–2032)
5.1.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021–2032)
5.2 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021–2032)
5.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021–2026)
5.2.2 Global Plaque Psoriasis Treatment Medications Revenue by Application (2027–2032)
5.2.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021–2032)
5.3 Global Plaque Psoriasis Treatment Medications Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Amgen Plaque Psoriasis Treatment Medications Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Company Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Allergan Plaque Psoriasis Treatment Medications Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Dermira
6.3.1 Dermira Company Information
6.3.2 Dermira Description and Business Overview
6.3.3 Dermira Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Dermira Plaque Psoriasis Treatment Medications Product Portfolio
6.3.5 Dermira Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Novartis Plaque Psoriasis Treatment Medications Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Merck Plaque Psoriasis Treatment Medications Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Johnson & Johnson
6.7.1 Johnson & Johnson Company Information
6.7.2 Johnson & Johnson Description and Business Overview
6.7.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pfizer Plaque Psoriasis Treatment Medications Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Company Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 AbbVie Plaque Psoriasis Treatment Medications Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 LEO Pharma
6.11.1 LEO Pharma Company Information
6.11.2 LEO Pharma Description and Business Overview
6.11.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio
6.11.5 LEO Pharma Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Company Information
6.12.2 Biogen Description and Business Overview
6.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Biogen Plaque Psoriasis Treatment Medications Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 Galectin Therapeutics
6.13.1 Galectin Therapeutics Company Information
6.13.2 Galectin Therapeutics Description and Business Overview
6.13.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio
6.13.5 Galectin Therapeutics Recent Developments/Updates
6.14 Cellceutix
6.14.1 Cellceutix Company Information
6.14.2 Cellceutix Description and Business Overview
6.14.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio
6.14.5 Cellceutix Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Company Information
6.15.2 Bayer Description and Business Overview
6.15.3 Bayer Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Bayer Plaque Psoriasis Treatment Medications Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Organon
6.16.1 Organon Company Information
6.16.2 Organon Description and Business Overview
6.16.3 Organon Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Organon Plaque Psoriasis Treatment Medications Product Portfolio
6.16.5 Organon Recent Developments/Updates
6.17 UCB
6.17.1 UCB Company Information
6.17.2 UCB Description and Business Overview
6.17.3 UCB Plaque Psoriasis Treatment Medications Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 UCB Plaque Psoriasis Treatment Medications Product Portfolio
6.17.5 UCB Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plaque Psoriasis Treatment Medications Industry Chain Analysis
7.2 Plaque Psoriasis Treatment Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plaque Psoriasis Treatment Medications Production Mode & Process Analysis
7.4 Plaque Psoriasis Treatment Medications Sales and Marketing
7.4.1 Plaque Psoriasis Treatment Medications Sales Channels
7.4.2 Plaque Psoriasis Treatment Medications Distributors
7.5 Plaque Psoriasis Treatment Medications Customer Analysis
8 Plaque Psoriasis Treatment Medications Market Dynamics
8.1 Plaque Psoriasis Treatment Medications Industry Trends
8.2 Plaque Psoriasis Treatment Medications Market Drivers
8.3 Plaque Psoriasis Treatment Medications Market Challenges
8.4 Plaque Psoriasis Treatment Medications Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Plaque Psoriasis Treatment Medications Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Plaque Psoriasis Treatment Medications Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Plaque Psoriasis Treatment Medications Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Plaque Psoriasis Treatment Medications Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Plaque Psoriasis Treatment Medications Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Plaque Psoriasis Treatment Medications Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Plaque Psoriasis Treatment Medications, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Product Types and Applications
 Table 12. Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Plaque Psoriasis Treatment Medications Companies by Tier (Tier 1, Tier 2, Tier 3), based on Plaque Psoriasis Treatment Medications Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Plaque Psoriasis Treatment Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Plaque Psoriasis Treatment Medications Sales by Region (K Units), 2021–2026
 Table 18. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021–2026)
 Table 19. Global Plaque Psoriasis Treatment Medications Sales by Region (K Units), 2027–2032
 Table 20. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2027–2032)
 Table 21. Global Plaque Psoriasis Treatment Medications Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021–2026)
 Table 23. Global Plaque Psoriasis Treatment Medications Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2027–2032)
 Table 25. North America Plaque Psoriasis Treatment Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2021–2026
 Table 27. North America Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2027–2032
 Table 28. North America Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Plaque Psoriasis Treatment Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2021–2026
 Table 32. Europe Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2027–2032
 Table 33. Europe Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Plaque Psoriasis Treatment Medications Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Plaque Psoriasis Treatment Medications Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Plaque Psoriasis Treatment Medications Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Plaque Psoriasis Treatment Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2021–2026
 Table 42. Latin America Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2027–2032
 Table 43. Latin America Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Plaque Psoriasis Treatment Medications Sales (K Units) by Type (2021–2026)
 Table 51. Global Plaque Psoriasis Treatment Medications Sales (K Units) by Type (2027–2032)
 Table 52. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021–2026)
 Table 53. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2027–2032)
 Table 54. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021–2026)
 Table 57. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2027–2032)
 Table 58. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Plaque Psoriasis Treatment Medications Sales (K Units) by Application (2021–2026)
 Table 61. Global Plaque Psoriasis Treatment Medications Sales (K Units) by Application (2027–2032)
 Table 62. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021–2026)
 Table 63. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2027–2032)
 Table 64. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Plaque Psoriasis Treatment Medications Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021–2026)
 Table 67. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2027–2032)
 Table 68. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Application (2027–2032)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Amgen Plaque Psoriasis Treatment Medications Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Allergan Company Information
 Table 76. Allergan Description and Business Overview
 Table 77. Allergan Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Allergan Plaque Psoriasis Treatment Medications Product
 Table 79. Allergan Recent Developments/Updates
 Table 80. Dermira Company Information
 Table 81. Dermira Description and Business Overview
 Table 82. Dermira Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Dermira Plaque Psoriasis Treatment Medications Product
 Table 84. Dermira Recent Developments/Updates
 Table 85. Eli Lilly Company Information
 Table 86. Eli Lilly Description and Business Overview
 Table 87. Eli Lilly Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Eli Lilly Plaque Psoriasis Treatment Medications Product
 Table 89. Eli Lilly Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Novartis Plaque Psoriasis Treatment Medications Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Merck Plaque Psoriasis Treatment Medications Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Johnson & Johnson Company Information
 Table 101. Johnson & Johnson Description and Business Overview
 Table 102. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Johnson & Johnson Plaque Psoriasis Treatment Medications Product
 Table 104. Johnson & Johnson Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Pfizer Plaque Psoriasis Treatment Medications Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. AstraZeneca Plaque Psoriasis Treatment Medications Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. AbbVie Company Information
 Table 116. AbbVie Description and Business Overview
 Table 117. AbbVie Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. AbbVie Plaque Psoriasis Treatment Medications Product
 Table 119. AbbVie Recent Developments/Updates
 Table 120. LEO Pharma Company Information
 Table 121. LEO Pharma Description and Business Overview
 Table 122. LEO Pharma Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. LEO Pharma Plaque Psoriasis Treatment Medications Product
 Table 124. LEO Pharma Recent Developments/Updates
 Table 125. Biogen Company Information
 Table 126. Biogen Description and Business Overview
 Table 127. Biogen Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Biogen Plaque Psoriasis Treatment Medications Product
 Table 129. Biogen Recent Developments/Updates
 Table 130. Galectin Therapeutics Company Information
 Table 131. Galectin Therapeutics Description and Business Overview
 Table 132. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product
 Table 134. Galectin Therapeutics Recent Developments/Updates
 Table 135. Cellceutix Company Information
 Table 136. Cellceutix Description and Business Overview
 Table 137. Cellceutix Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Cellceutix Plaque Psoriasis Treatment Medications Product
 Table 139. Cellceutix Recent Developments/Updates
 Table 140. Bayer Company Information
 Table 141. Bayer Description and Business Overview
 Table 142. Bayer Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Bayer Plaque Psoriasis Treatment Medications Product
 Table 144. Bayer Recent Developments/Updates
 Table 145. Organon Company Information
 Table 146. Organon Description and Business Overview
 Table 147. Organon Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Organon Plaque Psoriasis Treatment Medications Product
 Table 149. Organon Recent Developments/Updates
 Table 150. UCB Company Information
 Table 151. UCB Description and Business Overview
 Table 152. UCB Plaque Psoriasis Treatment Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. UCB Plaque Psoriasis Treatment Medications Product
 Table 154. UCB Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Plaque Psoriasis Treatment Medications Distributors List
 Table 158. Plaque Psoriasis Treatment Medications Customers List
 Table 159. Plaque Psoriasis Treatment Medications Market Trends
 Table 160. Plaque Psoriasis Treatment Medications Market Drivers
 Table 161. Plaque Psoriasis Treatment Medications Market Challenges
 Table 162. Plaque Psoriasis Treatment Medications Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Plaque Psoriasis Treatment Medications
 Figure 2. Global Plaque Psoriasis Treatment Medications Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Plaque Psoriasis Treatment Medications Market Share by Type: 2025 & 2032
 Figure 4. Biologics Product Picture
 Figure 5. Small Molecule Drugs Product Picture
 Figure 6. Non-biologic Drugs Product Picture
 Figure 7. Global Plaque Psoriasis Treatment Medications Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Plaque Psoriasis Treatment Medications Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Plaque Psoriasis Treatment Medications Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Plaque Psoriasis Treatment Medications Market Size (US$ Million), 2021–2032
 Figure 14. Global Plaque Psoriasis Treatment Medications Sales (K Units), 2021–2032
 Figure 15. Global Plaque Psoriasis Treatment Medications Average Price (US$/Unit), 2021–2032
 Figure 16. Plaque Psoriasis Treatment Medications Report Years Considered
 Figure 17. Plaque Psoriasis Treatment Medications Sales Share by Manufacturers in 2025
 Figure 18. Global Plaque Psoriasis Treatment Medications Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Plaque Psoriasis Treatment Medications Players: Market Share by Revenue in Plaque Psoriasis Treatment Medications in 2025
 Figure 20. Plaque Psoriasis Treatment Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Plaque Psoriasis Treatment Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021–2032)
 Figure 23. North America Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021–2032)
 Figure 24. United States Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021–2032)
 Figure 27. Europe Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021–2032)
 Figure 35. China Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Plaque Psoriasis Treatment Medications Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Plaque Psoriasis Treatment Medications by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Plaque Psoriasis Treatment Medications by Type (2021–2032)
 Figure 55. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Plaque Psoriasis Treatment Medications by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Plaque Psoriasis Treatment Medications by Application (2021–2032)
 Figure 58. Global Plaque Psoriasis Treatment Medications Price (US$/Unit) by Application (2021–2032)
 Figure 59. Plaque Psoriasis Treatment Medications Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String